1Howard PA, Chen JW, Crouch MA, et al. Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure. Ann Pharmacother,2006,40(4):1607-1617. 被引量：1
4Rutledge T,Reis VA,Linke SE,et al..Dep ression in heart failure a meta-analytic review of prevalence,intervention effects,and association with clinical outcomes. J Am Coll Cardiol, 2006,48 ( 8 ) : 1527-1537. 被引量：1
5Knudsen CW, Riis JS, Finsen AV, et al. Diagnostic value of a rapid test for B2type natriuretic peptide in patients presentingwith acute dyspnoe: effect of age and gender. Eur J Heart Fail, 2004,6 : 55- 62. 被引量：1
4[2]Gustafsson F,Torp-Pedersen C,Seibaek M,et al.Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure[J].Eur Heart J,2004,25(19):1711. 被引量：1
5[3]Gheorghiade M,Bonow RO.Chronic heart failure in the United States:a manifestation of coronary artery disease[J].Circulation,1998,97 (3):282-289. 被引量：1
6[5]Masoudi FA,Rathore SS,Wang Y,et al.National patterns of use and effectiveness of angiotensin converting enzyme inhibitors in older patients with heart failure and left yentricular systolic dysfunction[J].Circulation,2004,23(110):724-731. 被引量：1
7[1]Wiese S,Breyer T,Dragu A,et al.Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium:influence of angiotensin Ⅱ and diastolic fiber length[J].Circulation,2000,102(25):3074-3079. 被引量：1
8[2]Vasan RS,SULLIVAN LM,Roubenoff R,et al.Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction:the Framingham Heart Study[J].Circulation,2003,107(11):1486-1491. 被引量：1
